Difference between revisions of "Part:BBa K3506009"
(11 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K3506009 short</partinfo> | <partinfo>BBa_K3506009 short</partinfo> | ||
− | This part consists of two parts: CLB2 promoter and Cas9. Combining these two parts enables the CLB2 promoter to control the expression of Cas9, so as to achieve the goal of making the expression of Cas9 with the cell cycle. Prospectively, Cas9 expression begins at S phase and reaches its peak at G2/M phase. | + | This part consists of two parts: <i>CLB2</i> promoter and Cas9. Combining these two parts enables the <i>CLB2</i> promoter to control the expression of Cas9, so as to achieve the goal of making the expression of Cas9 with the cell cycle. Prospectively, Cas9 expression begins at S phase and reaches its peak at G2/M phase. |
Line 21: | Line 21: | ||
<b><font size="3">Design</font></b> | <b><font size="3">Design</font></b> | ||
− | We design a module to verify the periodic expression of Cas9, in which the gene | + | We design a module to verify the periodic expression of Cas9,in which the gene of Cas9 (BBa_K2130013) is put under the control of CLB2 promoter (K3506007). |
+ | [[Image:T--BNU-China--clb2-cas9.png|300px|border|center]] | ||
+ | |||
<b><font size="3">Experimental approach</font></b> | <b><font size="3">Experimental approach</font></b> | ||
− | 1. Construct recombinant plasmid .Get your target fragment and plasmid backbone (Cas9 and pRH003 in our experiment) . Get CLB2 promoter fragment from Saccharomyces cerevisiae S288C by PCR. Ligate the fragments by in-fusion cloning. | + | 1. Construct recombinant plasmid .Get your target fragment and plasmid backbone (Cas9 and pRH003 in our experiment) . Get <i>CLB2</i> promoter fragment from <i>Saccharomyces cerevisiae</i> S288C by PCR. Ligate the fragments by in-fusion cloning. |
− | 2. Transform the product (2.5μL) into E. coli DH5α competent cells(50μL), grow cells on each agar plate (containing Ampicillin). Incubate plates at 37°C overnight. Monoclones were selected by colony PCR. Expanding culture at 37℃ and 200rpm. Extract plasmids and sequence. | + | 2. Transform the product (2.5μL) into <i>E. coli</i> DH5α competent cells(50μL), grow cells on each agar plate (containing Ampicillin). Incubate plates at 37°C overnight. Monoclones were selected by colony PCR. Expanding culture at 37℃ and 200rpm. Extract plasmids and sequence. |
− | 3. Linearize the plasmids with Xho1 and transform them (5-10ng) into Saccharomyces cerevisiae BY4741. Grow cells on SD-ura plate and incubate at 30℃ for 3 days. Monoclones were selected by colony PCR and sequencing. | + | 3. Linearize the plasmids with Xho1 and transform them (5-10ng) into <i>Saccharomyces cerevisiae</i> BY4741. Grow cells on SD-ura plate and incubate at 30℃ for 3 days. Monoclones were selected by colony PCR and sequencing. |
− | 4. Synchronize Saccharomyces cerevisiae cells and release. | + | 4. Synchronize <i>Saccharomyces cerevisiae</i> cells and release. |
Several methods (Alpha Factor、Nutrient Depletion、Hydroxyurea) can be used to synchronize and release yeast cells. | Several methods (Alpha Factor、Nutrient Depletion、Hydroxyurea) can be used to synchronize and release yeast cells. |
Latest revision as of 09:18, 27 October 2020
The cassette of periodic expression of Cas9
This part consists of two parts: CLB2 promoter and Cas9. Combining these two parts enables the CLB2 promoter to control the expression of Cas9, so as to achieve the goal of making the expression of Cas9 with the cell cycle. Prospectively, Cas9 expression begins at S phase and reaches its peak at G2/M phase.
Usage
This part can be used to control Cas9 expression associated with the yeast cell cycle. If you want to control the expression of Cas9 during cell division, you can place this part on a yeast plasmid.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 229
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 812
Illegal BglII site found at 1607
Illegal BamHI site found at 1901
Illegal XhoI site found at 203
Illegal XhoI site found at 2407 - 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 1639
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 730
Illegal BsaI.rc site found at 1972
Illegal BsaI.rc site found at 3328
Illegal BsaI.rc site found at 3751
Illegal BsaI.rc site found at 3763
Illegal BsaI.rc site found at 4630
Illegal SapI.rc site found at 3435
Illegal SapI.rc site found at 4017
Illegal SapI.rc site found at 4032
Design
We design a module to verify the periodic expression of Cas9,in which the gene of Cas9 (BBa_K2130013) is put under the control of CLB2 promoter (K3506007).
Experimental approach
1. Construct recombinant plasmid .Get your target fragment and plasmid backbone (Cas9 and pRH003 in our experiment) . Get CLB2 promoter fragment from Saccharomyces cerevisiae S288C by PCR. Ligate the fragments by in-fusion cloning.
2. Transform the product (2.5μL) into E. coli DH5α competent cells(50μL), grow cells on each agar plate (containing Ampicillin). Incubate plates at 37°C overnight. Monoclones were selected by colony PCR. Expanding culture at 37℃ and 200rpm. Extract plasmids and sequence.
3. Linearize the plasmids with Xho1 and transform them (5-10ng) into Saccharomyces cerevisiae BY4741. Grow cells on SD-ura plate and incubate at 30℃ for 3 days. Monoclones were selected by colony PCR and sequencing.
4. Synchronize Saccharomyces cerevisiae cells and release.
Several methods (Alpha Factor、Nutrient Depletion、Hydroxyurea) can be used to synchronize and release yeast cells.
5. Collect the time-zero fraction. Then collect fractions of culture every 10 min for 120–180 min for Western Blot. Strain without plasmid transformation was used as the negative control. Don’t forget to select the internal reference.
6. Obtain and analyze data. Draw the image of protein levels over time.
References
[1]Trcek, T. , Larson, D. , Alberto Moldón, Query, C. , & Singer, R. . (2011). Single-molecule mrna decay measurements reveal promoter- regulated mrna stability in yeast. Cell, 147(7), 1484-1497.
[2]Michael D. Mendenhall, & Amy E. Hodge. (1998). Regulation of cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast saccharomyces cerevisiae.Microbiol Mol Biol Rev, 62(4), 1191-1243.
[3]Wu, X., Liu, L., & Huang, M. (2011). Analysis of changes in protein level and subcellular localization during cell cycle progression using the budding yeast Saccharomyces cerevisiae. Methods in molecular biology(Clifton,N.J.),782,47–57.
[4]Manukyan, A. , Abraham, L. , Dungrawala, H. , & Schneider, B. L. . (2011). Synchronization of yeast. Methods in Molecular Biology, 761(761), 173.
[5]Wang, Y. et al. A ‘suicide’ CRISPR-Cas9 system to promote gene deletion and restoration by electroporation in Cryptococcus neoformans. Sci. Rep. 6, 31145; doi: 10.1038/srep31145 (2016).
[6]Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., & Zhang, F. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science (New York, N.Y.), 339(6121), 819–823.